The value of conventional echocardiographic and tissue doppler imaging in the diagnosis of cardiac amyloidosis

Abstract

Transthoracic echocardiographic characteristics of 17 cases of cardiac amyloidosis (CA), a rare disease in China, were analyzed in order to improve the understanding of the disease. Seventeen cases of biopsy-proven CA, admitted to Wuhan Union Hospital from June 1994 to September 2008 were retrospectively reviewed. Twenty normal volunteers served as control group. Left atrial and ventricular functions and mitral inflow velocity were measured by two-dimensional, and Doppler echocardiography, and tissue Doppler imaging (TDI)-derived peak systolic wall motion velocities (Sv), peak early diastolic wall motion velocities (Ev), and peak late diastolic wall motion (Av) were measured at the septum, lateral, inferior and anterior corners of mitral annulus from the apical 4- and 2 chamber views. Compared with the control group, the interventricular septal thickness (IVSd), the left ventricular posterior wall (LVPWd), right ventricular transverse diameter (RVTDd) near the end of diastole and the interauricular septum thickness (IASs), left atrial anteroposterior diameter (LAADs), right atrial transverse diameter (RATDs) near the end of systole were increased significantly (all P<0.05) and left ventricular ejection fraction (LVEF) decreased (P<0.05) in the CA group. Compared with the control group, Sv, Ev at each wall and Av at almost all walls were significantly decreased in the CA group. In the CA group, Myocardial echoes of interventricular septum and free wall of left ventricle were enhanced evidently and distributed unevenly. The echoes presented as ground glass-like images, with some spotty hyper echoes. Both atria were enlarged, and LVEF decreased, with diastolic function impaired, and mild-moderate hydropericardium found in the CA group. It was concluded that echocardiography was a relatively sensitive and highly specific non-invasive method for the diagnosis of CA.

Keywords

echocardiography / TDI / amyloidosis / cardiomyopathy

References

[1] MerliniG., BellottiV.. Molecular mechanisms of amyloidosis. N Engl J Med, 2003, 349: 583-596

[2] KingmanA., PereiraN.L.. Cardiac amyloidosis. J S C Med Assoc, 2001, 97: 201-206

[3] WoodM. J., PicardM. H.. Utility of echocardiography in the evaluation of individuals with cardiomyopathy. Heart, 2004, 90: 707-712

[4] BellaviaD., AbrahamT. A., PellikkaP. A., et al.. Detection of left ventricular systolic dysfunction in cardiac amyloidosis with strain rate echocardiography. J Am Soc Echocardiogr, 2007, 20: 1194-1202

[5] FattoriR., RocchiG., CelletiF., et al.. Contribution of magnetic resonance imaging in the differential diagnosis of cardiac amyloidosis and symmetric hypertrophic cardiomyopathy. Am J Heart, 1998, 136: 824-830

[6] GarciaM. J., RodriguezL., AresM., et al.. Differentiation of constrictive pericarditis from restrictive cardiomyopathy: assessment of left ventricular diastolic velocities in longitudinal axis by Doppler tissue imaging. J Am Coll Cardiol, 1996, 27: 108-114

[7] OkiT., TabataT., YamadaH., AbeM., et al.. Right and left ventricular wall motion velocities as diagnostic indicators of constrictive pericarditis. Am J Cardiol, 1998, 81: 465-470

[8] OkiT., MishiroY., YamadaH.. Detection of left ventricular regional relaxation abnormalities and asynchrony in patients with hypertrophic cardiomyopathy with the use of tissue Doppler imaging. Am Heart J, 2000, 139: 497-502

[9] VinereanuD., IonescuA. A., FraserA. G.. Assessment of left ventricular long axis contraction can detect early myocardial dysfunction in asymptomatic patients with severe aortic regurgitation. Heart, 2001, 85: 30-36

[10] OkiT., TabataT., YamadaH., et al.. Clinical application of pulsed Doppler tissue imaging for assessing abnormal left ventricular relaxation. Am J Cardiol, 1997, 79: 921-928

[11] VogelsbergH., MahrholdtH., DeluigiC. C., et al.. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. J Am Coll Cardiol, 2008, 51: 1022-1030

[12] Cueto-GarciaL., ReederG. S., KyleR. A., et al.. Echocardiographic findings in systemic amyloidosis: spectrum of cardiac involvement and relation to survival. J Am Coll Cardiol, 1985, 6: 737-743

[13] LingJ. N., SunJ. P., YangX. S.. Cardiac amyloidosis. Chin J Med, 2006, 41: 49-51

[14] CrottyT. B., LiC. Y., EdwardsW. D., et al.. Amyloidosis and endomyocardial biopsy: correlation and extent and pattern of deposition with amyloid immunophenotype in 100 cases. Cardiovasc Pathol, 1995, 4: 39-42

[15] KingmanA., PereiraN. L.. Cardiac amyloidosis. J S C Med Assoc, 2001, 97: 201-206

[16] SmithR. R., HutchinsG. M.. Ischemic heart disease secondary to amyloidosis of intramyocardial arteries. Am J Cardiol, 1979, 44: 413-417

[17] SteinerI.. The prevalence of isolated atrial amyloid. J Pathol, 1987, 153: 395-398

[18] LooiL. M.. Isolated atrial amyloidosis: a clinicopathologic study indicating increased prevalence in chronic heart disease. Hum Pathol, 1993, 24: 602-607

[19] ChandrasekaranK., AylwardP. E., FleagleS. R., et al.. Feasibility of identifying amyloid and hypertrophic cardiomyopathy with the use of computerized quantitative texture analysis of clinical echocardiographic data. J Am Coll Cardiol, 1989, 13: 832-840

[20] TeiC., DujardinK. S., HodgeD. O., et al.. Doppler index combining systolic and diastolic myocardial performance: clinical value in cardiac amyloidosis. J Am Coll Cardiol, 1996, 28: 658-664

[21] DubreyS. W., ChaK., AndersonJ., et al.. The clinical features of immunoglobulin light 2 chain (L) amyloidosis with heart involvement. Q J Med, 1998, 91: 141-157

[22] RidolfiB. L., BulkleyB. H., HutchinsG. M.. The conductions system in cardiac amyloidosis: clinical and pathologic features of 23 patients. Am J Med, 1977, 62: 677-686

[23] KohnoI., KomoriS., YamamotoK., et al.. Hypertrophic cardiomyopathy complicated with cardiac amyloidosis. Intern Med, 2000, 39: 637-640

[24] McCarthyR. E., KasperE. K.. A review of the amyloidoses that infiltrate the heart. Clin Cardiol, 1998, 21: 547-552

[25] Siquiera-FilhoA. G., CunhaC. L., TajikA. J., et al.. M-mode and two dimensional echocardiographic features in cardiac amyloidosis. Circulation, 1981, 63: 188-196

[26] KristenA. V., PerzJ. B., SchonlandS. O., et al.. Non-invasive predictors of survival in cardiac amyloidosis. Eur J Heart Fail, 2007, 9: 617-624

[27] HuntS. A., BakerD. W., ChinM. H., et al.. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee to revise the 1995 guidelines for the evaluation and management of heart failure). Circulation, 2001, 104: 2996-3007

[28] GertzM. A., LacyM. Q., DispenzieriA., et al.. Amyloidosis. Hemato Oncol Clin North Am, 1999, 13: 1211-1233